Last updated: 21 days ago
Novo Nordisk's Comeback: The Battle for Weight-Loss Market Dominance
Explore Novo Nordisk's rebound in the weight-loss sector amid competition from Eli Lilly, Pfizer, and others. Key insights for investors in the evolving landscape of obesity treatments.